Home Institutions City of Hope clinical trials Institution Directory
Clinical trials at City of Hope Sites in Duarte, CA
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Nov 3, 2026, 10:29 PM EST
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1042
Current sort
Recently updated
Campus scope
City of Hope, Duarte, CA
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 757–768 of 1,042 matching trials with a site at City of Hope, Duarte, CA.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
Interventions Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Decitabine, Navtemadlin, Venetoclax Procedure · Drug
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 58 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2018 – 2027
U.S. locations 13
States / cities Duarte, California • Los Angeles, California • Pasadena, California + 6 more
Conditions Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma
Interventions Magnetic Resonance Imaging, Prophylactic Cranial Irradiation Procedure · Radiation
Lead sponsor SWOG Cancer Research Network Network
Eligibility 18 Years and older
Enrollment 668 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2029
U.S. locations 428
States / cities Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 328 more
Conditions Acute Myeloid Leukemia (AML)
Interventions Azacitidine, Venetoclax, Placebo Drug
Lead sponsor AbbVie Industry
Eligibility 18 Years and older
Enrollment 443 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2017 – 2026
U.S. locations 24
States / cities Duarte, California • Los Angeles, California • Sacramento, California + 17 more
Conditions Brain Metastases
Interventions Memantine, Hippocampal-avoidant (HA-WBRT) Radiotherapy, Stereotactic Radiosurgery (SRS) Drug · Radiation · Procedure
Lead sponsor Canadian Cancer Trials Group Network
Eligibility 18 Years and older
Enrollment 206 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2018 – 2027
U.S. locations 73
States / cities Tucson, Arizona • Corona, California • Duarte, California + 63 more
Conditions Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7
Interventions Ipilimumab, Laboratory Biomarker Analysis, Nivolumab, Quality-of-Life Assessment, Questionnaire Administration Biological · Other
Lead sponsor SWOG Cancer Research Network Network
Eligibility 18 Years and older
Enrollment 275 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2015 – 2027
U.S. locations 1201
States / cities Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 735 more
Conditions Stage IV Bladder Urothelial Carcinoma, Prostate Cancer, Urothelial Carcinoma
Interventions Computed Tomography, Laboratory Biomarker Analysis, Pembrolizumab, Positron Emission Tomography, Recombinant EphB4-HSA Fusion Protein Procedure · Other · Biological
Lead sponsor University of Southern California Other
Eligibility 18 Years and older
Enrollment 70 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2016 – 2030
U.S. locations 9
States / cities Duarte, California • Los Angeles, California • Newport Beach, California + 5 more
Conditions Desmoid, Desmoid Tumor
Interventions AL102, Placebo Drug · Other
Lead sponsor Immunome, Inc. Industry
Eligibility 12 Years and older
Enrollment 198 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2026
U.S. locations 23
States / cities Pheonix, Arizona • Duarte, California • Santa Monica, California + 17 more
Conditions Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8
Interventions Copper Cu 64 Anti-CEA Monoclonal Antibody M5A, Imaging Technique Biological · Procedure
Lead sponsor City of Hope Medical Center Other
Eligibility 18 Years and older
Enrollment 14 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2026
U.S. locations 1
States / cities Duarte, California
Conditions Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Interventions Biospecimen Collection, Dual-Energy Computed Tomography, Fluorothymidine F-18, Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Positron Emission Tomography Procedure · Drug · Other
Lead sponsor City of Hope Medical Center Other
Eligibility 18 Years and older
Enrollment 82 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2018 – 2026
U.S. locations 1
States / cities Duarte, California
Conditions Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer
Interventions 3-Dimensional Conformal Radiation Therapy (3D-CRT), Docetaxel, Gemcitabine, Intensity-Modulated Radiation Therapy (IMRT), Pemetrexed Disodium, Stereotactic Body Radiation Therapy (SBRT), Erlotinib Hydrochloride, Pembrolizumab Radiation · Drug
Lead sponsor NRG Oncology Other
Eligibility 18 Years and older
Enrollment 218 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2017 – 2028
U.S. locations 296
States / cities Birmingham, Alabama • Gilbert, Arizona • Peoria, Arizona + 228 more
Conditions Advanced Cutaneous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma
Interventions Biospecimen Collection, Internet-Based Intervention, Medical Device Usage and Evaluation, Phototherapy, Questionnaire Administration, Therapeutic Tumor Infiltrating Lymphocytes Procedure · Other · Biological
Lead sponsor City of Hope Medical Center Other
Eligibility 18 Years and older
Enrollment 8 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2027
U.S. locations 1
States / cities Duarte, California
Conditions Relapse Multiple Myeloma, Refractory Multiple Myeloma
Interventions Teclistamab Monotherapy, Teclistamab Drug
Lead sponsor Multiple Myeloma Research Consortium Network
Eligibility 18 Years to 99 Years
Enrollment 300 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2030
U.S. locations 13
States / cities Duarte, California • Atlanta, Georgia • Chicago, Illinois + 8 more About this City of Hope institution page
What this page lists ClinicalTrials.gov records that list City of Hope in Duarte, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , browse by condition , or browse by U.S. city .